Research Article
Microbial Predominance and Antimicrobial Resistance in a Tertiary Hospital in Northwest China: A Six-Year Retrospective Study of Outpatients and Patients Visiting the Emergency Department
Table 5
Annual multidrug resistance percentage (R%) of bacterial isolates from the specimens between 2013 and 2018 from outpatients and patients visiting emergency department.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ESBLs (extended spectrum β lactamases): ESBLs multidrug resistance was evaluated by using ceftriaxone. CRE (carbapenem-resistant enterobacteriaceae): CRE multidrug resistance was evaluated by using imipenem and meropenem. MRSA (methicillin-resistant S. aureus): MRSA multidrug resistance was evaluated by using oxacillin. MRSE (methicillin-resistant S. epidermidis): MRSE multidrug resistance was evaluated by using oxacillin. |